Edit |   |
---|---|
Antigenic Specificity | CD123/IL3RA (Talacotuzumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Talacotuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD123/IL3RA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Talacotuzumab, also known as JNJ-56022473 (and formerly CSL-362) is a humanized IgG1 monoclonal antibody designed to bind to and neutralize CD123 (Interleukin-3 receptor alpha chain or IL3RA) with potential antineoplastic activity. |
Immunogen | n/a |
Other Names | Talacotuzumab, CD123/IL3RA, 1826831-79-1 |
Gene, Accession # | CAS: 1826831-79-1 |
Catalog # | abx831435 |
Price | please inquire |
Order / More Info | CD123/IL3RA (Talacotuzumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950